LAXATIF BIOCANINA
LAXATIF BIOCANINA
Authorised
- Docusate sodium
- Sodium laurilsulfate
Product identification
Medicine name:
LAXATIF BIOCANINA
Active substance:
- Docusate sodium
- Sodium laurilsulfate
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Docusate sodium30.00/milligram(s)1.00Tablet
-
Sodium laurilsulfate30.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Not applicableno withdrawal periodWithdrawal period is 0 days
-
-
Dog
-
Not applicableno withdrawal periodWithdrawal period is 0 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA06AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Europeenne De Pharmacotechnie Europhartech
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/0048193 1/1989
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 8/12/2022
How useful was this page?:
